BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Lauretis A, Renzoni EA. Molecular Biomarkers in Interstitial Lung Diseases. Mol Diagn Ther 2014;18:505-22. [DOI: 10.1007/s40291-014-0109-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Dhar R, Mukherjee S, Mukerjee N, Mukherjee D, Devi A, Ashraf GM, Alserihi RF, Tayeb HH, Hashem AM, Alexiou A, Thorate N. Interrelation between extracellular vesicles miRNAs with chronic lung diseases. J Cell Physiol 2022. [PMID: 36063496 DOI: 10.1002/jcp.30867] [Reference Citation Analysis]
2 García-río F, Alcázar-navarrete B, Castillo-villegas D, Cilloniz C, García-ortega A, Leiro-fernández V, Lojo-rodriguez I, Padilla-galo A, Quezada-loaiza CA, Rodriguez-portal JA, Sánchez-de-la-torre M, Sibila O, Martínez-garcía MA. [Translated article] Biological Biomarkers in Respiratory Diseases. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2022.01.010] [Reference Citation Analysis]
3 Ibrahim A, Ibrahim A, Parimon T. Diagnostic and Therapeutic Applications of Extracellular Vesicles in Interstitial Lung Diseases. Diagnostics (Basel) 2021;11:87. [PMID: 33430301 DOI: 10.3390/diagnostics11010087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kouranos V, Miranda G, Corte TJ, Renzoni EA. New treatment paradigms for connective tissue disease-associated interstitial lung disease. Curr Opin Pulm Med 2018;24:453-60. [PMID: 30020142 DOI: 10.1097/MCP.0000000000000508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Mishra S, Shah MI, Sarkar M, Rout C. Integrated analysis of non-coding RNAs for the identification of promising biomarkers in interstitial lung diseases. Gene Reports 2018;11:87-93. [DOI: 10.1016/j.genrep.2018.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Benyamine A, Heim X, Resseguier N, Bertin D, Gomez C, Ebbo M, Harlé JR, Kaplanski G, Rossi P, Bardin N, Granel B. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Rheumatol Int 2018;38:813-9. [PMID: 29455320 DOI: 10.1007/s00296-018-3987-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
7 Drakopanagiotakis F, Wujak L, Wygrecka M, Markart P. Biomarkers in idiopathic pulmonary fibrosis. Matrix Biol 2018;68-69:404-21. [PMID: 29408012 DOI: 10.1016/j.matbio.2018.01.023] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 10.3] [Reference Citation Analysis]
8 Campo I, Zorzetto M, Bonella F. Facts and promises on lung biomarkers in interstitial lung diseases. Expert Review of Respiratory Medicine 2015;9:437-57. [DOI: 10.1586/17476348.2015.1062367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]